19 reports

The synthesized oligonucleotide segment is further segmented as, DNA oligonucleotides, RNA oligonucleotides, and others.

  • Genomics
  • Oligonucleotide
  • World
  • Forecast

Market Size and Forecast by Geography ##. ## North America Oligonucleotide Synthesis Market ##. ##. ## North America Oligonucleotide Synthesis Market, by Product ##. ##. ## North America Oligonucleotide Synthesis Market, by Application ##. ##. ## North America Oligonucleotide Synth

  • Genomics
  • Oligonucleotide
  • World
  • Forecast
  • ANTISENSE OLIGONUCLEOTIDE TO INHIBIT TGF-BETA2 FOR OPHTHALMOLOGY
  • ANTISENSE OLIGONUCLEOTIDE TO INHIBIT TGF-BETA1 FOR OPHTHALMOLOGY
  • Antisense Oligonucleotide
  • Oligonucleotide
  • Isarna Therapeutics GmbH
  • Roche Group
  • Santaris Pharma a/s
  • 6.2 SYNTHESIZED OLIGONUCLEOTIDES
  • OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION
  • Oligonucleotide
  • World
  • Forecast
  • Market Size
  • Agilent Technologies, Inc.
  • OLIGONUCLEOTIDE TO ACTIVATE DYSTROPHIN FOR DUCHENNE MUSCULAR DYSTROPHY - DRUG PROFILE
  • ANTISENSE OLIGONUCLEOTIDE TO ACTIVATE DYSTROPHIN FOR DUCHENNE MUSCULAR DYSTROPHY -...
  • Oligonucleotide
  • Therapy
  • United States
  • Product Initiative
  • Sarepta Therapeutics, Inc.
  • Oligonucleotide to Agonize TLR3 for Oncology
  • OLIGONUCLEOTIDE TO AGONIZE TLR3 FOR ONCOLOGY - DRUG PROFILE
  • Biopharmaceutical
  • Immunology
  • Oligonucleotide
  • Vaccine
  • Hemispherx Biopharma, Inc.
  • PARENT
  • Genomics
  • Oligonucleotide
  • United States
  • Company
  • ProQR Therapeutics N.V.
  • ANTISENSE RNAI OLIGONUCLEOTIDE TO INHIBIT MICRORNA FOR METABOLIC DISEASE PRODUCT DESCRIPTION
  • ANTISENSE RNAI OLIGONUCLEOTIDES FOR ONCOLOGY AND ORPHAN DISEASES PRODUCT DESCRIPTION
  • microRNA
  • Oligonucleotide
  • United States
  • Product Initiative
  • Regulus Therapeutics Inc.
  • RNAI OLIGONUCLEOTIDE FOR CLOTTING DISORDER
  • RNAI OLIGONUCLEOTIDE FOR RARE LIVER DISEASES
  • Oligonucleotide
  • Pharmaceutical
  • R&D
  • Research And Development
  • Dicerna Pharmaceuticals, Inc.
  • OLIGONUCLEOTIDE FOR HIV
  • OLIGONUCLEOTIDE FOR CANCER
  • Monoclonal Antibody
  • Oligonucleotide
  • Vaccine
  • United States
  • CureVac GmbH
  • OLIGONUCLEOTIDES FOR NON-ALCOHOLIC STEATOHEPATITIS PRODUCT DESCRIPTION
  • ANTISENSE OLIGONUCLEOTIDE TO INHIBIT IL-17 FOR RHEUMATOID ARTHRITIS PRODUCT DESCRIPTION
  • Oligonucleotide
  • Chad
  • World
  • Product Initiative
  • AuraSense Therapeutics LLC

Product Description RNAI OLIGONUCLEOTIDE TO INHIBIT CTGF FOR PVR R& D Progress RNAi oligonucleotide to inhibit CTGF for PVR is under development.

  • Oligonucleotide
  • RNAi
  • United States
  • Product Initiative
  • RXi Pharmaceuticals Corporation

The drug candidate is a ##-mer antisense oligonucleotide.

  • Oligonucleotide
  • Research And Development
  • United States
  • Product Initiative
  • Sarepta Therapeutics, Inc.
  • OLIGONUCLEOTIDE FOR NEUROINFLAMMATION
  • ANTISENSE OLIGONUCLEOTIDE TO ACTIVATE DYSTROPHIN FOR DUCHENE MUSCULAR DYSTROPHY
  • Oligonucleotide
  • Research And Development
  • Therapy
  • United States
  • World
  • ANTISENSE OLIGONUCLEOTIDE 2 TO INHIBIT HUNTINGTIN PROTEIN FOR HUNTINGTON'S DISEASE...
  • R&D Progress Research and Development Brief
  • Neurological Disorder
  • Oligonucleotide
  • Therapy
  • United States
  • Product Initiative
  • RNAI OLIGONUCLEOTIDE FOR UNDISCLOSED INDICATION
  • RNAI OLIGONUCLEOTIDES FOR GENETIC DISEASES
  • Oligonucleotide
  • Therapy
  • United States
  • Product Initiative
  • Alnylam Pharmaceuticals, Inc.

It is an antisense oligonucleotide.

  • Antisense Technology
  • Oligonucleotide
  • Pharmaceutical
  • United States
  • Isis Pharmaceuticals, Inc.
  • RNAI OLIGONUCLEOTIDES FOR MYOTONIC DYSTROPHY
  • RNAI OLIGONUCLEOTIDES FOR DUCHENNE MUSCULAR DYSTROPHY
  • microRNA
  • Oligonucleotide
  • R&D
  • Therapy
  • Marina Biotech, Inc.
  • Biosearch Technologies targets and partners (2012 -YTD2016)

Other The oligonucleotide manufacturing division belongs to DNA Technology A/ S, a provider of custom-manufactured synthetic oligonucleotides.

  • Genomics
  • Oligonucleotide
  • United States
  • M&A
  • Biosearch Technologies, Inc.